Near Infrared Imaging Market (2026 - 2033)

Near Infrared Imaging Market Summary

The near infrared imaging market size was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 3.2 billion by 2033, at a CAGR of 3.8% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 42.5% in 2025. Increasing incidence of target diseases, such as cardiovascular diseases (CVDs), gastrointestinal, neurovascular, and cancer, is likely to boost the demand for near infrared imaging in the coming years.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to the WHO, CVDs account for about 17.9 million deaths each year globally. Moreover, growing demand for technologically advanced fluorescence imaging systems and various initiatives undertaken by key market players is anticipated to boost the overall market growth. For instance, in May 2024, Hamamatsu Photonics K.K., based in Hamamatsu City, Japan, completed the acquisition of NKT Photonics A/S, enhancing its capabilities in lasers, detectors, and advanced photonics solutions.

To learn more about this report, Download Free Sample Report

The COVID-19 pandemic affected the market for near infrared imaging as these are critical care medical devices and are mainly used during surgical procedures. The restrictions led to a decrease in demand for near infrared imaging devices as the medical settings redirected their sources on essential and life-saving devices. However, now since the pandemic restrictions have been lifted, the market is expected to grow at a significant rate over the forecast period. According to the annual report published by Olympus, recovery from COVID-19’s effects led to positive growth from the previous fiscal year in the surgical endoscopes market. Sales of surgical endoscopic system VISERA ELITE II were especially robust in North America and Europe.

Increase in the adoption of surgical interventions has augmented the usage of visualization equipment to perform the surgery. Microsurgery has been chosen by several individuals on large scale due to rising prevalence of chronic diseases caused by stress, work pressure, improper eating habits, sedentary lifestyle, exposure to chemicals, and heredity. Furthermore, increasing awareness among the population owing to the benefits of treating a medical condition with surgery at the proper stage is boosting the demand for surgical procedures, thereby increasing adoption rate of near infrared imaging. According to a report published by American Society of Plastic Surgeons, cosmetic procedures in the U.S. saw a 5% increase between 2022 and 2023, reaching a total of 1,575,244 procedures in 2023. These factors are expected to positively impact the market during the forecast period. Hence, the rise in surgical procedures is expected to fuel the market for near infrared imaging over the forecast period.

A constant rise in the geriatric population is increasing the financial burden on the healthcare system. According to the Global Health and Aging report by the WHO, the number of people with age 65 and more is anticipated to rise from approximately 524 million in 2010 to nearly 1.5 billion by 2050, especially in developing economies. Such a rise in the elderly population base will subsequently result in the greater application of near infrared imaging, hence supporting market growth.

Near-infrared imaging has a wide range of applications including physiological diagnostics and study of pulse oximetry, blood sugar, sports medicine, urology, and neurology. Besides, there are more than 250 clinical trials to explore potential applications of this technique in other applications. Early detection of Alzheimer’s disease with the help of non-invasive near-infrared spectroscopy is expected to have a significant impact on the usage of the NIR technique in neurology. Functional near-infrared spectroscopy is integrated with optical imaging technology and is increasingly used in the neuroimaging domain.

Market Dynamics

The near-infrared imaging market is witnessing significant growth due to the increased adoption of fluorescence guided imaging technology by healthcare organizations, research institutes, and life science companies in order to enhance visualization and disease diagnostics. Near infrared imaging makes use of fluorescent contrast agents along with imaging systems designed to work with near infrared wavelengths, which enables the visualization of various tissues, blood vessels, lymphatic system, and tumors with better tissue penetration and low background autofluorescence. The market includes near-infrared fluorescence imaging systems, near-infrared fluorescence along with bioluminescence imaging systems and imaging reagents such as indocyanine green (ICG) and other targeted fluorescent markers. The applications include preclinical imaging, cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic and reconstructive surgeries and many more image guided surgeries. The factors fueling the growth of this market include minimally invasive surgeries, rising incidence rates of cancer and cardiovascular diseases, growing demands for image-guided surgeries and advances in fluorescence imaging technology.

Analyst Perspective

The near-infrared imaging market is positioned at the intersection of precision surgery, molecular imaging, and personalized medicine. The increasing focus on increasing surgical accuracy, minimizing risk of complications, and improving patient outcome is leading to rising use of fluorescence-based imaging in oncology, cardiovascular, gastroenterology, and reconstructive surgeries. Innovations in target-specific fluorescent dyes, multi-spectral imaging techniques, AI-driven image interpretation, and robotic surgeries are making Near-Infrared Imaging technology more clinically relevant and versatile than before. Also, rising investments in translational research, pre-clinical imaging, and pharmaceutical drugs discovery are opening up new avenues for imaging equipment vendors and dye providers. With increasing emphasis on minimally invasive surgeries and precise interventions, Near-Infrared Imaging technologies are poised to see continued adoption.

Product Insights

Based on product, the reagent segment led the market with the largest revenue share of 57.1% in 2025. Reagents offer several advantages over traditional visible light dyes, including high sensitivity and specific detection in biological systems. Reagents are sub-categorized as Indocyanine Green (ICG) and other reagents. The reagents segment is expected to grow considerably during the forecast period owing to the benefits offered by ICG. Indocyanine green offers real-time angiographic images during brain tumor or vascular surgery. Moreover, it is increasingly being used for spine surgery. Hence, growing applications of ICG along with its advantages are the major drivers of the segment.

Near infrared imaging devices are projected to experience substantial growth over the forecast period. The rising prevalence of diseases such as cardiovascular conditions, cancer, and gastrointestinal disorders is driving demand for advanced imaging techniques such as near infrared (NIR) imaging, which offers non-invasive, real-time visualization essential for early diagnosis and treatment planning. Technological advancements have led to portable fluorescence imaging systems, enabling point-of-care diagnostics, while integration of AI and automation enhances efficiency and accuracy. Moreover, the growing trend toward minimally invasive procedures and increased research applications, particularly in drug development and precision medicine, further underscore the relevance of NIR imaging technologies.

Disease Indication Insights

Based on disease indication, the preclinical imaging segment led the market with the largest revenue share of 33.9% in 2025. NIR reagents play a crucial role in preclinical imaging research for studying diseases such as cancer, inflammation, and infection. Advanced NIR reagents, such as the COX-2 probe developed by PerkinElmer Inc., enhance fluorescence and tissue penetration, facilitating faster clinical development of oncology drugs. Monitoring cerebral oxygenation during cardiovascular procedures is vital for improving surgical outcomes, further driving NIR imaging adoption.

The cancer surgeries segment is expected to witness the fastest growth with a CAGR of 4.9% over the forecast period, owing to the increasing prevalence of cancer on a global scale. NIR imaging enhances surgical precision by providing real-time visualization of tumors, enabling accurate differentiation between cancerous and healthy tissues, which is crucial for complete tumor resection. It effectively assesses surgical margins using agents such as indocyanine green (ICG), particularly in breast-conserving surgeries, and is a non-invasive option that promotes safer procedures and shorter recovery times. As acceptance grows, ongoing research continues to improve NIR imaging capabilities, making it a versatile and valuable tool across various surgical techniques. For instance, according to International Agency for Research on Cancer 2022, approximately 1,185,216 cases of cancer were recorded in Africa in 2022, the same source states that the number is expected to reach 50,550,287 by 2025.

End Use Insights

Based on end use, the hospitals & cinics segment led the market with the largest revenue share of 46.0% in 2025. This growth is owing to an increase in the number of admissions of cancer patients in clinics and hospitals and well-established healthcare facilities in developed countries. Near infrared technologies are widely used in hospitals and clinics for detection of bedsores to prevent surgical errors. Laparoscopic devices integrated with near infrared sensors help surgeons to avoid accidental cutting of blood vessels. The adoption of these devices helps in reducing surgical errors and minimizing the duration of hospital stay and healthcare costs for patients. The increasing patient demand for minimally invasive and efficient surgical methods is expected to boost the demand for near infrared products.

To learn more about this report, Download Free Sample Report

The pharmaceutical and biotechnology companies segment is anticipated to witness significant growth over the forecast period. Near infrared imaging is used in pharmaceutical companies to measure the critical material attributes of a product. They are used in pharmaceutical and biotechnology companies for identification of raw materials, verification of the quality of lyophilized materials, monitoring coating and content of tablets, monitoring fermentation and cell culture, and various in-line and on-line process monitoring.

Regional Insights

North America dominated the near infrared imaging market with the largest revenue share of 42.5% in 2025. This growth is owing to the high disposable income of consumers, speedy adoption of technologically advanced medical devices, and diagnostic techniques. A large number of cancer cases reported in the country are expected to boost the market in the U.S. According to International Agency for Research on Cancer, approximately 292,098 new cancer cases were identified in Canada in 2022. In addition, rise in the number of reconstructive and cosmetic surgeries in the country owing to increased spending and rising awareness regarding early diagnosis is expected to create robust growth opportunities.

To learn more about this report, Download Free Sample Report

U.S. Near Infrared Imaging Market Trends

The near infrared imaging market in the U.S. held the largest share in the North America region in 2025. A combination of demographic trends, technological advancements, and a shift toward minimally invasive procedures is enhancing the effectiveness of diagnostic and surgical practices in healthcare. The aging population increases the demand for advanced imaging technologies, while the rising preference for minimally invasive techniques benefits from real-time visualization provided by near-infrared imaging. Continuous innovations cater to diverse needs, and FDA regulations ensure safety, fostering provider trust.

Europe Near Infrared Imaging Market Trends

Europe near infrared imaging market held substantial market share in 2024, fueled by continuous advancements in imaging technology that enhance medical diagnostics, surgical guidance, and tissue analysis, leading to broader adoption. The rising demand for non-invasive procedures emphasizes the need for real-time visualization during surgeries, while increasing cancer incidence in Europe heightens the demand for precise tumor localization. Favorable regulatory support and research applications in preclinical studies also contribute to market expansion.

The near infrared imaging market in Germany is expected to grow lucratively in the forecast period. The increasing adoption across medical diagnostics, industrial inspection, and agricultural monitoring remain primary drivers for market growth in the country. Continuous technological advancements, including the integration of artificial intelligence and advanced fluorescent agents, enhance visualization performance. Rising demand for non-invasive diagnostics and the growing prevalence of chronic diseases, such as cancer and cardiovascular conditions, also contribute to market expansion. Moreover, the increased use of NIR imaging in minimally invasive surgeries fuels this growth.

Asia Pacific Near Infrared Imaging Market Trends

Asia Pacific near infrared imaging market is expected to register the fastest CAGR of 4.4% in the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost the growth of the market in the region. The presence of a huge population base with low per capita income in the Asia Pacific region has led to high demand for affordable treatment options. Multinational companies are keen to invest in developing countries, such as Japan, India, South Korea, and more. Thus, many market players are entering into strategic alliances with local players. This is anticipated to augment the near infrared imaging market growth.

The near infrared imaging market in Japan dominated the Asia Pacific near infrared imaging market in 2024. The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, has heightened demand for advanced imaging technologies, particularly NIR imaging, which facilitates non-invasive diagnostics and enhances patient outcomes. In March 2024, artience Co., Ltd. launched the high-sensitivity near-infrared fluorescence probe “Sciforiem FI Series” in Japan, enhancing cell and exosome dynamics observation for therapeutic and diagnostic applications.

Key Near Infrared Imaging Company Insights

Some key companies operating in the market include Quest Diagnostics Incorporated; Stryker; KARL STORZ SE & Co. KG; among others. The key players are focusing on growth strategies, such as new product launches, expansion, collaborations, partnerships, and acquisitions. For instance, in October 2024, Lynred, headquartered in France, acquired New Imaging Technologies to enhance its infrared sensor offerings, including large-format shortwave sensors, addressing growing market demands in aerospace and defense.

• KARL STORZ SE & Co. KG is dedicated to developing innovative endoscopic solutions. Their advanced NIR/ICG imaging systems significantly enhance visualization during surgical procedures, improving overall operational efficiency.

• Hamamatsu Photonics K.K. excels in the design and manufacture of optoelectronic devices and imaging systems, including near-infrared technologies. Their high-resolution imaging solutions are widely utilized in medical diagnostics, research, and industrial applications, ensuring exceptional performance across various sectors.

Key Near Infrared Imaging Companies

The following key companies have been profiled for this study on the near infrared imaging market.

• Quest Diagnostics Incorporated

• Stryker

• KARL STORZ SE & Co. KG

• Olympus

• Hamamatsu Photonics K.K.

• Mizuho Medical Co., Ltd.

• Shimadzu Corporation

• Leica Microsystems

• Medtronic (Visionsense)

• PerkinElmer

• Zeiss Group

• FLUOPTICS SAS

Recent Developments

• In February 2025, Stryker, headquartered in Portage, Michigan, completed the acquisition of Inari Medical, enhancing its position in the high-growth peripheral vascular market focused on venous thromboembolism treatment solutions.

• In February 2025, Leica Microsystems, based in Wetzlar, Germany, acquired ATTO-TEC, enhancing its microscopy imaging workflows and research capabilities by integrating advanced fluorescent dyes and reagents into its product portfolio.

• In November 2024, Hamamatsu Photonics K.K., headquartered in Hamamatsu City, Japan, acquired BAE Systems Imaging Solutions, enhancing its opto-semiconductor segment by incorporating advanced CMOS image sensor technologies.

Global Near Infrared Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global near infrared imaging market report based on product, indication, end use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Devices

    • Near-infrared Fluorescence Imaging Systems

    • Near-infrared Fluorescence & Bioluminescence Imaging Systems

  • Reagents

    • Indocyanine Green (ICG)

    • Other Reagents

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Preclinical Imaging

  • Cancer Surgeries

  • Gastrointestinal Surgeries

  • Cardiovascular Surgeries

  • Plastic/Reconstructive Surgeries

  • Other Applications

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics

  • Pharmaceutical & Biotechnology Companies

  • Research Laboratories

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The near infrared imaging market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each near infrared imaging segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations